Detalhe da pesquisa
1.
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies.
Br J Cancer
; 129(9): 1389-1396, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542109
2.
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.
Oncologist
; 28(6): e391-e396, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014824
3.
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Cancer Immunol Immunother
; 72(11): 3839-3850, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733060
4.
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Oncology
; 99(9): 555-561, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247166
5.
Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19.
Health Econ
; 30(3): 699-707, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368853
6.
Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors.
Br J Clin Pharmacol
; 86(9): 1769-1777, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424951
7.
Patient-Centered Oncology or Population-Centered Oncology-Which Do We Want, and Which Tradeoffs Are We Willing To Accept?
Oncologist
; 24(3): 288-290, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523149
8.
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
Oncologist
; 24(11): 1469-1478, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320502
9.
A Cost-Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First-Line Intermediate- to Poor-Risk Advanced Renal Cell Carcinoma.
Oncologist
; 24(3): 366-371, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30710066
10.
Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer.
Cost Eff Resour Alloc
; 17: 5, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867655
11.
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer.
Lancet Oncol
; 24(6): 589-593, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146621
12.
Correction to: Extended duration of treatment using reducedfrequency dosing of antiPD1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Cancer Immunol Immunother
; 72(12): 4471, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979010
13.
A real-world analysis of cancer drug wastage due to oversized vials.
J Am Pharm Assoc (2003)
; 58(6): 643-646, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30017368
14.
Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable Condition.
Oncologist
; 22(5): 623-625, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424322
15.
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.
Oncologist
; 22(6): 694-699, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28592621
16.
Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving Trastuzumab.
Ann Pharmacother
; 50(9): 712-7, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27307412
17.
Costs and effectiveness of genomic testing in the management of colorectal cancer.
Oncology (Williston Park)
; 29(3): 175-83, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25783977
18.
Early Steps in the Value of Cancer Care-Many Paths Remain Unexplored.
Oncologist
; 23(4): 391-392, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438095
19.
Denosumab for bone lesions in multiple myeloma - what is its value?
Haematologica
; 103(5): 753-754, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29712820
20.
Effect of stearidonic acid-enriched soybean oil on fatty acid profile and metabolic parameters in lean and obese Zucker rats.
Lipids Health Dis
; 12: 147, 2013 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24139088